Purchaser Stock Consideration. The Closing Shares will be, prior to the issuance, duly authorized, and when issued in accordance with the terms of this Agreement, will be validly issued, fully paid and non-assessable.
Appears in 3 contracts
Sources: Share Purchase Agreement (Synthetic Biologics, Inc.), Equity Purchase Agreement (Adial Pharmaceuticals, Inc.), Stock Purchase Agreement (Heat Biologics, Inc.)
Purchaser Stock Consideration. The Closing Shares will be, prior to the issuance, duly authorized, and when issued in accordance with the terms of this Agreement, will be validly issued, fully paid and non-assessable.. The Closing Shares shall represent upon issuance nineteen percent (19%) of the then issued and outstanding shares of Purchaser Common Stock
Appears in 1 contract
Sources: Membership Interest Purchase Agreement (Safe & Green Development Corp)